Dave, C. V., Brittenham, G. M., Carson, J. L., & Setoguchi, S. (2022). Risks for Anaphylaxis With Intravenous Iron Formulations. Annals of Internal Medicine, 175(11), W143–W144. https://doi.org/10.7326/l22-0283

Li, X., Ostropolets, A., Makadia, R., Shoaibi, A., Rao, G., Sena, A. G., Martinez-Hernandez, E., Delmestri, A., Verhamme, K., Rijnbeek, P. R., Duarte-Salles, T., Suchard, M. A., Ryan, P. B., Hripcsak, G., & Prieto-Alhambra, D. (2021). Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. BMJ, n1435. https://doi.org/10.1136/bmj.n1435

Dave, C. V., Brittenham, G. M., Carson, J. L., & Setoguchi, S. (2022). Risks for Anaphylaxis With Intravenous Iron Formulations. Annals of Internal Medicine, 175(5), 656–664. https://doi.org/10.7326/m21-4009